The short answer
Care may include supportive treatment for low blood counts, medicines that affect the disease, chemotherapy, or donor stem cell transplant. The plan depends on subtype, risk, symptoms, age, and health. The most useful conversation starts with the goal of treatment and the exact disease features driving the recommendation.
Which of your blood counts is low shapes the plan as much as the diagnosis does: red cells cause anemia and breathlessness, white cells raise infection risk, platelets raise bleeding risk.
Supportive care such as transfusions, growth factors and antibiotics is real treatment, not a lesser option, especially in lower-risk disease.
Donor stem cell transplant is the only potentially curative option, and is generally reserved for people fit enough for it and disease that justifies the risk.
Some subtypes carry a real risk of progressing to acute myeloid leukemia, so ask what your risk category is and how it shapes monitoring.
Choose how you want to understand this
The full explanation.
The short answer
Myelodysplastic syndromes are a group of blood cancers. Immature blood cells in your bone marrow do not mature into healthy blood cells the way they should. These defective cells often die in the marrow. Sometimes they die shortly after entering your bloodstream. This leaves you with too few healthy blood cells. Treatment depends on your specific risk category and which blood counts are most affected.
Why blood counts, not just diagnosis, drive treatment
Low blood counts from myelodysplastic syndromes can cause different problems. It depends on which count is low. Low red blood cells cause anemia. This leads to fatigue and shortness of breath. Low white blood cells raise infection risk. Low platelets raise bleeding and bruising risk. Your team's treatment choices are shaped by which of these is most affecting you. It is not just about the diagnosis itself.
Supportive care: managing symptoms directly
Blood transfusions treat low red blood cell counts. They ease fatigue and shortness of breath. Growth factors, called erythropoiesis-stimulating agents, can help your body make more red blood cells on its own. This sometimes reduces how often you need transfusions. Antibiotics treat infections when they occur, which is more likely with low white blood cell counts. This supportive care is real treatment, not a lesser option. This is especially true for people whose disease is lower risk.
Drug therapies that target the disease
Lenalidomide reduces how often some patients need transfusions. This works particularly well for a specific genetic subtype of myelodysplastic syndromes. Azacitidine and decitabine work by targeting rapidly dividing cells. They help restore more normal gene activity in your bone marrow. These are commonly used for higher-risk disease. Immunosuppressive treatments calm an overactive immune response. They are an option for specific situations. Ask your team which drug fits your specific subtype and risk level.
Stem cell transplant: the only potentially curative option
Stem cell transplant uses donor stem cells after high-dose chemotherapy. It offers the chance of a cure for some patients. It is a more intensive treatment. It is generally reserved for patients fit enough to handle it, with disease that justifies the risk. Say your myelodysplastic syndrome developed after previous cancer treatment. Transplant may be less effective. Ask your team how your history factors into this option.
Why leukemia risk is part of the conversation
Certain types of myelodysplastic syndromes carry a real risk of progressing to acute myeloid leukemia. This is especially true for types with a higher share of immature cells in the bone marrow. Drug therapies are used partly to slow this progression. Ask your team what your specific risk category is. Also ask how it shapes both your treatment plan and how closely you will be monitored.
Which symptoms cannot wait
A fever of 100.4°F (38°C) or higher is an emergency in myelodysplastic syndromes. Ring your team's urgent number the moment you see it, day or night, and go to an emergency department if you cannot reach anyone quickly. The disease itself keeps white blood cell counts low, and azacitidine, decitabine and transplant conditioning push them lower still, so an infection can become dangerous within hours. Say on arrival that you have a blood cancer and low counts. Chest pain is a separate matter: call 911 or go to an emergency department for it, and do the same if you are breathless at rest. Call your care team the same day for unusual bleeding or bruising, or for shortness of breath on exertion that is new or worsening. These need prompt evaluation, not a wait for your next scheduled visit.
What to ask your care team
- What is my specific risk category, and how was it determined?
- Which of my blood counts are most affected, and what is being done about each one?
- Am I a candidate for stem cell transplant?
- What symptoms should prompt a same-day call rather than waiting for my next appointment?
Sources
Words to know
Tap any term to see what it means.
Common questions
Which of my blood counts matters most for treatment?
Whichever one is causing you problems. Low red cells cause anemia, fatigue and shortness of breath. Low white cells raise infection risk. Low platelets raise bleeding and bruising risk. Ask which of yours is most affected and what is being done about each one.
Are transfusions and growth factors just holding measures?
No. Supportive care is real treatment. Transfusions ease fatigue and breathlessness, erythropoiesis-stimulating agents can help your body make more red cells and sometimes reduce how often you need transfusions, and antibiotics treat infection when it happens. For lower-risk disease this may be the main plan.
Can myelodysplastic syndrome be cured?
A donor stem cell transplant after high-dose chemotherapy offers the chance of a cure for some people. It is intensive and is generally reserved for those fit enough to handle it. If your myelodysplastic syndrome developed after previous cancer treatment, transplant may be less effective, so ask how your history factors in.
Will this turn into leukemia?
Certain subtypes carry a real risk of progressing to acute myeloid leukemia, particularly those with a higher share of immature cells in the bone marrow. Drug therapies such as azacitidine and decitabine are used partly to slow that progression. Ask what your specific risk category is and how closely you will be monitored.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Turn this guide into a short list for your care team.
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-08-13 what this meansLast updated: 2026-08-19Next planned review: 2027-01-22
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share